Author

K. Fisher-Wellman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

M. Cabot· 2 shared M. Montgomery· 2 shared R. Aruleba· 2 shared S.-F. Tan· 2 shared T. Zeczycki· 2 shared A. Pereyra· 1 shared A. Schimmer· 1 shared B. Chrest· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Cabot

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Acute myeloid leukemia mitochondria hydrolyze ATP to resist chemotherapy

J. T. Hagen, M. Montgomery, R. Aruleba, B. Chrest, T. D. Green, M. Kassai, T. Zeczycki, C. A. Schmidt, D. Bhowmick, S.-F. Tan, D. Feith, C. Chalfant, T. Loughran, D. Liles, M. Minden, , K. Fisher-Wellman

This study identifies a bioenergetic mechanism in AML cells where mitochondria consume ATP to resist chemotherapy, offering a target for improving treatment.

bioRxiv · Apr 12, 2024 · PreprintCancer Biology

Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across tumor types

I. Boykov, M. Montgomery, J. Hagen, R. Aruleba, K. McLaughlin, H. Coalson, M. Nelson, A. Pereyra, J. Ellis, T. Zeczycki, N. Vohra, S.-F. Tan, M. Cabot, K. Fisher-Wellman

The paper evaluates mitochondrial OXPHOS expression and function across murine tumors and normal tissues, finding lower OXPHOS levels in tumors compared to normal and high OXPHOS organs.

bioRxiv · Jun 4, 2023 · PreprintBiochemistry